đź“‹ FDA Reference

philips gyroscan t5 ii release 3

Philips Medical Systems

Summary: The Philips Gyroscan T5 II Release 3 is an MRI system used for diagnostic imaging. It is primarily utilized by radiologists for assessing various medical conditions through detailed imaging of internal structures.

FDA Clearance Information

Pathway 510K
Decision Date January 25, 1994
Product Code LNH
Device Class Class 2
Evidence 419 studies

The Philips Gyroscan T5 II Release 3 was cleared by the FDA via the 510k pathway on January 25, 1994. Manufactured by Philips Medical Systems, it is classified as a Class 2 device under product code LNH.

What It Is

The Philips Gyroscan T5 II Release 3 is a magnetic resonance imaging (MRI) system designed to provide high-resolution images of the body's internal structures. It operates by using strong magnetic fields and radio waves to generate detailed images, which are crucial for diagnosing a wide range of medical conditions. This device is part of the advanced imaging technology that aids clinicians in visualizing soft tissues, organs, and other internal body parts without the use of ionizing radiation.

Clinical Applications

This MRI system is commonly used in hospitals and diagnostic imaging centers for a variety of clinical scenarios, including neurological, musculoskeletal, and cardiovascular imaging. It is particularly valuable in specialties such as radiology, neurology, and orthopedics. The device is used to assess conditions like brain tumors, spinal cord injuries, joint abnormalities, and vascular diseases, providing critical information for treatment planning.

Indications for Use

The FDA indications for the Philips Gyroscan T5 II Release 3 include its use in obtaining detailed images of the body's internal structures, which is essential for diagnosing and monitoring various medical conditions. It is suitable for patients requiring non-invasive imaging for conditions affecting the brain, spine, joints, and other soft tissues.

Practical Considerations

When using the Philips Gyroscan T5 II Release 3, clinicians should be aware of the typical MRI safety protocols, including screening for metal implants and ensuring patient comfort during the procedure. The device is compatible with standard MRI-compatible accessories and requires routine maintenance to ensure optimal performance.

Related Literature

The linked study investigated changes in intracranial volume following the cross-clamping of the descending thoracic aorta in pigs, using MRI technology. The study aimed to understand the physiological effects of aortic cross-clamping on brain volume, which is relevant for surgical procedures involving the aorta. Key findings indicated potential alterations in intracranial volume, highlighting the importance of monitoring such changes during surgery. However, the study's limitations include its animal model, which may not fully translate to human physiology.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is the Philips Gyroscan T5 II Release 3 used for?

It is used for obtaining detailed MRI images of the body's internal structures, aiding in the diagnosis and monitoring of various medical conditions.

What specialties typically use this device?

Radiology, neurology, and orthopedics are the primary specialties that utilize this MRI system for diagnostic imaging.

What are the FDA-cleared indications?

The device is indicated for producing high-resolution images of internal body structures, useful for diagnosing conditions affecting the brain, spine, joints, and soft tissues.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.